Patient Engagement

Patients always at heart.

A recent report released by The Economist Intelligence Unit (EIU)¹ and commissioned by us confirmed what we’ve known for years – that drugs developed with patients at heart are more likely to launch.

Throughout our years helping discoveries come to market, one thing has remained constant – the more patient-focused the process, the better. That’s why all our services take patient input to heart before, during and after a clinical study.

Source: The Innovation Imperative: The Future of Drug Development, The Economist Intelligence Unit, 2018.

Patient-focused at every point

Pre-Study:

• We design protocols to identify and address potential practical barriers to study participation
• We use a combination of web listening, patient, caregiver, and site staff input to get a clear picture of the patient burdens to best care for volunteers through recruitment and retention
• We proactively seek opportunities to address the needs of commercial stakeholders and build a better value story
• Our regulatory experts incorporate guidance to address agency requirements from a patient-focused perspective

During Study:

• To make the process as easy as possible for patients, we can help with eConsent, home nursing, direct-to-patient drug shipments, patient apps, and video dosing
• Our Patient Sensor Solution allows for continuous data collection with wearables to remotely capture, transmit, and store data in a secure platform

Market Access and Beyond

• We can help patients understand study outcomes and ways to transition to a post-study treatment plan
• To get needed therapies to market as quickly as possible, we identify and develop ways to speed up market access
• Through our Managed Access Programs we facilitate early access to promising new medicines for patients with unmet needs